Click on image to view larger version.

Figure 1. Sema 3C stimulates MGEC adhesion and induces ß1 integrin phosphorylation. Adhesion of MGEC to fibronectin (A), collagen (B), and gelatin (C), at each substrate concentration of 1 µg/ml, were assessed in the absence (control) or in the presence of sema 3C (180 ng/ml) or VEGF (30 ng/ml). D) Dose response to sema 3C (180 to 480 ng/ml) showing that sema 3C regulates MGEC adhesion to fibronectin, *P < 0.05 control vs. sema 3C, **P < 0.05 sema 3C 480 vs. 180 ng/ml; E) MGEC adhesion to fibronectin (1 µg/ml) in the absence (control=gray bars) or in the presence of sema 3C (360 ng/ml; red bars) with or without antibodies blocking
5 ß1,
V ß3, or both
5 ß1 and
V ß3 integrins. Data are mean ± SE of 3 separate experiments, carried out in quadruplicate, *P < 0.05 control vs.
5 ß1 or
V ß3 blocking antibodies, #P < 0.05 sema 3C vs.
5 ß1 or
V ß3 blocking antibodies. F) Western blot showing a 2-fold increase in phosphorylated Ser-785ß1 integrin at 30 min, reprobed with an anti-actin Ab to document equal loading. G) Western blot showing that NP1 and NP2 neutralizing antibodies prevent sema 3C-induced Ser-785ß1 integrin phosphorylation, whereas VEGF and VEGFR2 neutralizing antibodies do not. H) Western blot showing phosphorylated Y397 FAK and total FAK showing that sema 3C did not alter FAK tyrosine phosphorylation. Western blots are representative of
3 separate experiments.